Tag: Dr Michael Manning

COUR Pharma Pipeline

COUR Announces First In-Human Dosing in Proof-of-Concept Trial of CNP-201 to...

CNP-201 is a nanoparticle containing peanut protein that aims to eliminate allergic responses.